Oscar Health (OSCR) to Release Quarterly Earnings on Thursday

Oscar Health (NYSE:OSCR - Get Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Parties interested in participating in the company's conference call can do so using this link.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. During the same quarter in the prior year, the business earned ($0.07) earnings per share. The business's quarterly revenue was up 44.6% compared to the same quarter last year. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Trading Down 1.3 %

Shares of Oscar Health stock traded down $0.22 during trading hours on Thursday, hitting $16.82. The company's stock had a trading volume of 3,292,789 shares, compared to its average volume of 3,205,367. Oscar Health has a 1-year low of $4.84 and a 1-year high of $23.79. The business has a fifty day moving average of $18.74 and a 200 day moving average of $18.36. The company has a market capitalization of $4.07 billion, a PE ratio of -129.38, a P/E/G ratio of 32.07 and a beta of 1.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26.

Insider Activity

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

OSCR has been the subject of several recent research reports. Piper Sandler reissued an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $24.00.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.